, Australia
166 views
/Nayeli Leal Uh from Unsplash

QBE's conservative investments support stability

Its net/net combined ratio improved to 91.2% for 2023.

QBE Insurance proved itself to have a very strong balance sheet strength, robust operating performance, favourable business profile, and sound enterprise risk management, AM Best said.

QBE’s risk-adjusted capitalisation, as measured by Best’s Capital Adequacy Ratio (BCAR), remains at the strongest level, with expectations of maintaining this level in the future. 

The group’s conservative investment portfolio and appropriate reinsurance program support this assessment. QBE benefits from strong financial flexibility due to its regular capital market activities and has reduced financial leverage in recent years. 

Whilst the group generally shows a trend of favourable prior-year reserve development, adverse development was noted in 2022 and 2023, mainly due to North American operations.

QBE’s strong operating performance is highlighted by its solid underwriting performance and diverse earnings. The net/net combined ratio improved to 91.2% for 2023, a 3.8 percentage point increase from 2022. 

The group’s favourable business profile is attributed to its excellent geographic diversification and strong market positions in global commercial lines insurance.

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.